VENLO, the Netherlands, July 16, 2015 /PRNewswire/ --
QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans to release its report on results for the second quarter of 2015 on Wednesday, July 29, at 22:00 Central European Time (CET) / 16:00 Eastern Time (ET). A conference call is planned for Thursday, July 30, at 15:30 CET / 9:30 ET hosted by Peer M. Schatz, Chief Executive Officer, and Roland Sackers, Chief Financial Officer.
Conference Call & Webcast Details
The conference call will begin at 15:30 CET / 9:30 ET on July 30, 2015.
Interested parties may listen to the call by dialing: +1-631-302-6547 (U.S.), +44-203-059-5869 (UK), +49-69-566-036-000 (Germany)
The webcast will be accessible at http://www.qiagen.com/de/about-us/investors/corporate-calendar.
A conference call replay will be available through August 6 2015, by dialing:
+1-724-5589-653 (U.S.), +44-121-260-4861 (UK), +49-69-710-488-70 (Germany) (passcode: 446482#).
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. QIAGEN sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective molecular testing workflows. QIAGEN provides these workflows to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). As of March 31, 2015, QIAGEN employed approximately 4,300 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.
Vice President Corporate Communications and Investor Relations